Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.

/PRNewswire/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FSE: 4960), a leader in the treatment and research of mental...

Related Keywords

New York ,United States ,Texas ,Washington ,Colorado ,Florida ,Montreal ,Quebec ,Canada ,California ,State Of Florida ,Toronto ,Ontario ,Ottawa ,Canadian ,American ,Roger Mcintyre ,Sanjiv Chopra ,Daniel Herrera ,Kaia Roman ,Edward Pearson ,Warren Gumpel ,Joshua Rosenblat ,Yousifa Rahim ,Daniel Kang ,Leann Taylor ,Braxia Scientific Corp ,International Expert Opinion ,Mental Health ,Ketamd Inc ,Ketamine Fund ,Warner Music Group ,Braxia Scientific Company ,Excellence Inc ,Clinical Research Organization ,Canadian Securities Exchange ,Ketamd Company ,Canadian Rapid Treatment Center ,Gartner Inc ,Professor Of Medicine At Harvard Medical School ,Amwell Research ,Health Canada ,Access Program ,World Psychiatry ,Zappy Zapolin ,Chief Operating Officer ,Mental Health Challenge ,Consideration Shares ,Earnout Shares ,Maturity Date ,Benchmark Price ,Tuesday August ,Chief Experience Officer Kaia Roman ,Joy Plan ,Silicon Valley ,Medical Director ,Chief Medical Officer ,Harvard Medical School ,Covenant Physical Partners ,Scientific Company Highlights ,Expert Opinion ,Available Evidence ,American Journal ,Health Canada Approved ,Special Access Program ,Major Depressive Disorder ,Controlled Drugs ,Substances Act ,Restated Listing Statement ,